New insights into the potential for new classes of HIF inhibitors to restore control of the hypoxia response — representing the potential foundation of a new cancer-fighting strategy — are the focus of recently published research.
New insights into the potential for new classes of HIF inhibitors to restore control of the hypoxia response — representing the potential foundation of a new cancer-fighting strategy — are the focus of recently published research.